SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Presti who wrote (933)10/15/1997 12:30:00 AM
From: Bob Frey   of 1172
 
The "Bird in the Hand" thing got me today as I sold all my CMTR for a 47% Profit. I look Forward to getting back in at about 3/4.

The Home Drug test kit has a suggested retail of $ 49.95. CVS will be selling for about $ 44.95. CVS suggested they will have the kit in all their stores buy the end of the year. I do not look forward to a very positive reporting from CMTR for this or the next quarter.

As far as the A/M deal goes I would think if there was a lot of money in the product A/M would have never canceled the deal.

The stock seems to have been run up on hype and down on profit taking. It also seems there are more profits that could be taken from here.

Long term the company may have a chance with the drug kit but it will take a great marketing effort to sell the kit when you can go to a local lab and get a drug test done for about $ 30.00.

There has been no mention of a offering of shares to raise more funds for the marketing efforts but I bet it won't be long before we here about one. The other thing that I was thinking is that with the new rules at NASDAQ a rev split may be needed if the stock does not stay above a buck.

Good Luck To Ya!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext